FSGS Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study

Kidney International Reports(2024)

引用 0|浏览12
暂无评分
关键词
focal segmental glomerulosclerosis,sparsentan,dual endothelin angiotensin receptor antagonist,randomized controlled clinical trial,pediatric,race
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要